ERBB2 and neoplasm: Statistical analysis of significant differences in CN and MUT status of only the minimal EN genes for the cisplatin sensitive and resistant tumor cells (listed in Table 1) finds that sensitivity to cisplatin is associated with MUTs in EWS_FLI1, PTEN, ERBB2 and APC (http://cancer.CGP.ac.uk/CGP/gene/overview?ln=APC and Niedner et al.[19]).